HRM primer set for identifying CPV and FPV, kit containing primer set, and applications of kit
A kit and primer set technology, applied in recombinant DNA technology, microbial assay/inspection, biochemical equipment and methods, etc., to achieve good sensitivity and specificity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Example 1 Primer Design
[0031] Download the whole genome sequences of canine parvovirus and feline parvovirus from GenBank, and find stable gene fragments with base differences through MEGA7 comparison analysis (reference strain: CPV Laika-1993, accession number: JN033694.1), design A pair of qPCR primers (F2 / R2) for distinguishing between CPV and FPV. A pair of primers (F1 / R1) were designed to amplify gene fragments including qPCR amplified fragments to construct CPV and FPV standard plasmids. The primer sequences are shown in Table 1.
[0032] Table 1 Primer Sequence
[0033]
Embodiment 2
[0034] The establishment of embodiment 2 high resolution melting curve (HRM) method
[0035] 1. Construction of standard plasmids
[0036] Take 200ul CPV virus stock solution and FPV virus stock solution respectively, and extract virus DNA. The operation steps were carried out according to the operating instructions of TAKARA's MiniBEST Viral RNA / DNA Extraction Kit Ver.5.0. Use the DNA extracted by the kit as a template, use F1 / R1 (Table 1) as a primer, and refer to Taq TM (Ex Taq TM Version 2.0plus dye) (Takara, RR902A) operating instructions for PCR amplification, PCR system (50ul) as shown in Table 2.
[0037] Table 2 PCR system (50ul)
[0038]
[0039]
[0040] The pre-amplification reaction program was as follows: pre-denaturation at 95°C for 5 min; denaturation at 95°C for 30 s, annealing at 50°C for 1 min, extension at 72°C for 2 min; cycle 35 times; final extension at 72°C for 10 min.
[0041] Prepare a 3% gel with diluted buffer (1×TAE). Take 5ul of the P...
Embodiment 3
[0053] Embodiment 3 clinical application
[0054] Collect 80 clinical samples suspected of being infected with canine parvovirus or feline parvovirus from Beijing, Shenyang, Shijiazhuang and Changchun, conduct clinical testing according to the HRM method established in Example 2, and compare with tests such as virus isolation and DNA sequence determination Compare. The results of HRM analysis revealed that there were 42 CPV positive samples and 6 FPV positive samples. 45 samples were successfully sequenced, 39 samples were positive for CPV and 6 samples were FPV positive. The virus isolation test was carried out on 80 samples, and 32 strains of CPV and 4 strains of FPV were obtained. Compared with DNA sequencing, the coincidence rate, relative specificity and sensitivity of the HRM method were 96.25%, 91.43%, and 100% respectively; compared with the virus isolation test, the coincidence rate, relative specificity and sensitivity of the HRM method were 85% , 72.72%, 100%.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com